Israel Englander Zynerba Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.3 - $0.43 $99,154 - $142,121	-330,514 Reduced 72.43%	125,835 $41,000
Q1 2023 May 15, 2023	SELL	$0.4 - $0.67 $41,515 - $69,538	-103,789 Reduced 18.53%	456,349 $196,000
Q4 2022 Feb 14, 2023	SELL	$0.5 - $0.72 $18,731 - $26,972	-37,462 Reduced 6.27%	560,138 $297,000
Q3 2022 Nov 14, 2022	BUY	$0.87 - $1.36 $255,822 - $399,906	294,049 Added 96.87%	597,600 $437,000
Q2 2022 Aug 15, 2022	BUY	$0.86 - $2.06 $261,053 - $625,315	303,551 New	303,551 $346,000
Q4 2021 Feb 14, 2022	SELL	$2.88 - $4.3 $1.12 Million - $1.67 Million	-387,602 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.72 - $5.35 $3,169 - $4,558	-852 Reduced 0.22%	387,602 $1.64 Million
Q2 2021 Aug 16, 2021	BUY	$3.83 - $5.98 $1.4 Million - $2.19 Million	366,074 Added 1635.72%	388,454 $2.06 Million
Q1 2021 May 17, 2021	BUY	$3.33 - $8.76 $74,525 - $196,048	22,380 New	22,380 $104,000
Q4 2020 Feb 16, 2021	SELL	$3.27 - $4.64 $644,451 - $914,451	-197,080 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.23 - $4.3 $57,245 - $76,208	-17,723 Reduced 8.25%	197,080 $652,000
Q2 2020 Aug 14, 2020	BUY	$3.31 - $6.54 $710,997 - $1.4 Million	214,803 New	214,803 $724,000
Q4 2019 Feb 14, 2020	SELL	$5.61 - $8.57 $130,914 - $199,989	-23,336 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.56 - $15.44 $41,421 - $84,595	5,479 Added 30.68%	23,336 $176,000
Q2 2019 Aug 15, 2019	SELL	$5.4 - $15.5 $1.1 Million - $3.17 Million	-204,434 Reduced 91.97%	17,857 $242,000
Q2 2019 Aug 14, 2019	BUY	$5.4 - $15.5 $1.09 Million - $3.12 Million	201,581 Added 973.35%	222,291 $12 Million
Q1 2019 May 14, 2019	SELL	$3.6 - $6.22 $35,618 - $61,540	-9,894 Reduced 32.33%	20,710 $112,000
Q4 2018 Feb 14, 2019	SELL	$2.89 - $7.91 $356,334 - $975,295	-123,299 Reduced 80.11%	30,604 $91,000
Q3 2018 Nov 14, 2018	SELL	$5.59 - $10.45 $394,698 - $737,853	-70,608 Reduced 31.45%	153,903 $1.26 Million
Q2 2018 Aug 14, 2018	BUY	$7.98 - $12.39 $962,148 - $1.49 Million	120,570 Added 116.0%	224,511 $2.19 Million
Q1 2018 May 15, 2018	BUY	$8.49 - $13.46 $882,459 - $1.4 Million	103,941 New	103,941 $903,000

Others Institutions Holding ZYNE

# of Institutions

Shares Held

774K

Call Options Held

Put Options Held

View Full List

About Zynerba Pharmaceuticals, Inc.

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

More about ZYNE

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account